Tokyo, Japan Related Funds
| Fund Name | Location |
| ABR Capital Management | California, San Francisco, United States |
| AO Capital Partners | China, Hong Kong, Hong Kong Island |
| ARTKB | - |
| Centauri Fund | - |
| Chapter One Ventures | California, Los Angeles, United States |
| China Eurasian Economic Cooperation Fund | - |
| East Coast Angels | New Hampshire, Portsmouth, United States |
| Furui Jiacheng Investment Management | China, Songjiang, Songjiang District |
| Greenlight Capital | New York, New York, United States |
| Groupe Rossel | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| Jubilant Biosys | Bengaluru, India, Karnataka |
| Kapyon Ventures | California, San Diego, United States |
| Neusoft Group | China, Liaoning, Shenyang |
| Quire | New York, New York, United States |
| Sabey Healthcare Holdings | - |
| Sante Ventures | Austin, Texas, United States |
| Traton | Bayern, Germany, Munich |
| Wallstreet Group | - |
| Washington Research Group | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Diabeloop | $82M | 02 Jun 2022 | Grenoble, Auvergne-Rhône-Alpes, France | ||
ReThink Medical | $3M | 01 May 2017 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Diabeloop | $82M | 02 Jun 2022 | Grenoble, Auvergne-Rhône-Alpes, France | ||
ReThink Medical | $3M | 01 May 2017 | San Francisco, California, United States |
